Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Amazon
AMZN
CN Stock MarketDetailed Quotes
300813 TAILIN
- 17.13
- +0.39+2.33%
Trading Apr 29 14:58 CST
2.08BMarket Cap194.66P/E (TTM)
17.24High16.53Low22.68KlotVolume16.60Open16.74Pre Close38.66MTurnover2.98%Turnover Ratio158.61P/E (Static)121.20MShares29.8052wk High2.52P/B1.30BFloat Cap14.1352wk Low20.09Limit Up76.05MShs Float66.50Historical High13.39Limit Down4.24%Amplitude10.78Historical Low0.10Dividend TTM17.05Avg Price9.56KlotAsk0.58%Div YieldTTM100Lot Size12.15KlotBid
TAILIN News
Tailin Biotech: Announcement on the intention to sign a high-performance filter and supporting functional film industrialization project contract and foreign investment with the Hangzhou Fuchun Bay New Town Management Committee
Tailin Biotech: Announcement on changing the registered capital and amending the “Articles of Association”
Tailin Biotech: Announcement on the Company and its wholly-owned subsidiaries applying for comprehensive credit lines from banks
Tailin Biotech: An indicative announcement on the disclosure of the report for the first quarter of 2025
Tailin Biotech: 2024 Financial Results Report
Tailin Biotech: Report on the 2024 Assessment Report on the Performance Status of Accounting Firms
Tailin Biotech: Summary table on the use of non-operating capital and other related capital transactions in 2024
Tailin Biotech: Opinions of Great Wall Securities Co., Ltd. on the verification of Zhejiang Tailin Biotechnology Co., Ltd. on issuing convertible corporate bonds to unspecified targets in 2021 to raise capital investment projects and invest the savings raised into new projects and permanently supplement working capital
Tailin Biotech: Announcement on the 2025 Remuneration Plan for Directors, Supervisors and Senior Management
Tailin Biotech: Report of the Audit Committee on the performance of supervisory duties by accounting firms in 2024
Tailin Biotech: Notice on Convening the 2024 Annual General Meeting of Shareholders
Tailin Biotech: Announcement on the conclusion of a fund-raising investment project by issuing convertible corporate bonds to unspecified targets in 2021 and investing the savings raised into new projects and permanently replenish working capital
Tailin Biotech: Prompt Announcement on the Disclosure of the 2024 Annual Report
Tailin Biotech: Announcement on the Use of Some Idle Funds Raised and Own Funds for Cash Management
Tailin Biotech: Legal Opinion of Guohao Lawyer (Hangzhou) Firm on the 2025 First Extraordinary General Meeting of Shareholders of Zhejiang Tailin Biotechnology Co., Ltd.
Tailin Biotech: Announcement of Resolutions of the 2025 First Extraordinary General Meeting of Shareholders
Tailin Biotech: Announcement on Establishing a Wholly-owned Subsidiary and Obtaining a Business License
Tailin Biotech: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025
Tailin Biotech: Announcement of Staff Congress Resolutions
Tailin Biotech: Verification Opinions of Great Wall Securities Co., Ltd. on the extension of Zhejiang Tailin Biotechnology Co., Ltd.\'s fund-raising investment project to issue convertible corporate bonds to unspecified targets
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts?